MyDx Inc. (fka MYDX)

[stervc]

Part 2: Significant MYDX Research Per Unknown Investor

After reading Part 1 of the MYDX link/post below, consider the thoughts shared in Part 2 that's following:
Part 1- https://investorshub.advfn.com/boards/read_msg.aspx?message_id=130514928

[/quote]

Part 2

The company is currently focused on 4 key business segments to service the cannabis industry:

I. Consumer Products

Smart Devices & Consumables

1.) CannaDx

- The cannabis industry’s first hand-held cannabis sensor and analyzer with disposable single use inserts.

- Comes with a mobile app that acts as a ‘virtual budtender’.

- Analyzes cannabis sample and provides a Total Canna Profile TM (TCP), a more complete chemical profile to include THC and the most prevalent cannabinoids and terpenes found in cannabis plants.

- Cannabinoids such as THC and CBD have been reported to bind the CB1 and CB2 receptors found throughout the human body and have been reported to provide relief to an array of symptoms, including pain, nausea, and inflammation to name a few. Terpenes, which have been reported to compound the effects of cannabinoids on the body via an “Entourage Effect”, are also important in determining the overall physiological effects various cannabis chemical profiles.

- Enables users to log their ailments and side effects and tie those back to the exact chemical profile

- Provides strain recommendations based on desired “relief” input based on crowdsourced community feedback.

2.) Delivery Devices

- MyDx plans to develop smart hardware that gather user data

- Integrated with Bluetooth as well as other technologies that will allow for mobile-app control, dose restrictions, safety controls, and usage statistics.

- We plan to OEM these product to third-party customers

3.) MyDx 2

- MyDx plans to develop he first touchscreen kitchen tablet in the market with integrated MyDx sensor reading capability

- Sensor lineup to include OrganaDx, AquaDx, and AeroDx.

- Company plans to offer CannaDx data portal management ability in MyDx2.

MyDx plans to evaluate 510K approval process to leverage its consumer products and the ability of insurance companies to support sales of its smart devices and generate HIPPA compliant crowdsourced data.


II. Data Analytics

Pre-Clinical Chemical Analysis and Patient Feedback Ecosystem

MyDx will have four classes of data and algorithms:

1) User Data
- When users download the CannaDx mobile app, we may ask them put in personal details such as gender, location, height, weight, age etc. that we maintain while complying with HIPAA.

2) Chemical Composition Data
- This information is sourced from a number of inputs including the CannaDx Handheld’s Total Canna Profile (TCP), partner laboratories analyses, and branded pre-tested concentrates.

3) User Feedback
- Provided by users in our CannaDx mobile app as they try various products and record their experiences with those products.

4) Usage Statistics
- We will capture type, frequency, dosage, ailments relieved, and side effects.

MyDx plans to leverage this data, which combined is referred to as the Total Canna Profile TM (TCP), combined with our proprietary algorithms, to develop key insights into user behavior based on unique chemical profiles. Our goal is to track how a specific sample is expected to help relieve certain ailments and to validate the results.

III. Biopharmaceutical

Identifying ‘green Active Pharmaceutical Ingredients TM ’ (gAPI TM ) and corresponding formulations

1) Sale and License of Product Formulations

- MyDx plans to work with third party customers to license crowdsourced formulated chemical profiles that are expected to address a specific “relief” desired using its own proprietary formulas derived from our extensive dataset and algorithms.

2) Sale of green Active Pharmaceutical Ingredients (gAPI TM )

- This division will also look to provide an organic source of extracted green Active Pharmaceutical Ingredients (gAPI TM ), such as a predefined terpene formulation, for consumer and industrial use.

- Given that certain classes of gAPI’s such hemp derived CBD and terpenes might offer “relief” without the “high” THC provides, MyDx intends to partner with leaders in the industry to offer branded products without THC, akin to a “virgin” cocktail, if it finds that these formulations offer the benefits desired and the legal framework to sell them is viable.


IV. SaaS (Software as a Service)

Software services for prescribers, patient groups, cultivators, and regulators

1) MyDx App

- Available in iOS and Android and controls the MyDx Analyzer

- Tracks patient tested samples and physiological feedback

- Prints a Certificate of Analysis, which includes patient feedback

- Offers patients groups and their doctors with OEM software to track what the community is experiencing

- Centrally hosted in our secure cloud based server

- Will offer in App purchases for additional software subscription features

2) Software to Support Laboratory Marketing, Customer Service and Data Aggregation

- MyDx will offer what we believe will be the premier lead generator and outsourced services provider for cannabis testing labs

- Through certain assets MyDx expects to develop or acquire, as well as leads generated from our handheld analysis and smart devices, we believe MyDx will be positioned to become a world leader in cannabis laboratory marketing and services and as the largest “data holder” of tested cannabis and the associated chemical profiles tied to the ailment therapy.

https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12005181

[/quote]

MYDX's database will now include cannabis oil brands, some which may claim similar chemical profiles and effects compared to one another. "Trust and Verify" is the trademarked company motto.

http://tmsearch.uspto.gov/bin/showfield?f=doc&state=4810:g3ion9.2.4

[/quote]

You will be able to enter the brand name of the cannabis oil you are using with the pen into the app and database for monitoring any correlation between usage and effects:

Passive Monitoring
The ECO Smart Pen(TM) immediately activates the MyDx App via bluetooth as soon as you put in any compatible cartridge, so that you can input the brand name you’re using. Once the product information is submitted, the pen will then passively monitor your consumption habits, such as frequency of use.

https://www.cdxlife.com/ecosmartpen/

As an example:
If two brands of oil claim the same profile and/or effect but one takes 4 puffs and another takes 1 puff for the same effect on you, then the app for the pen can log that difference in the database for future reference by others and consumers can then explore why that is. Maybe one brand is diluting their oils and another is not. How else could you know?

[/quote]

The Eco-pen may possibly be covered by the pending patent application as a “delivery device”:

Apparatus for detection and delivery of volatilized compounds and related methods US 20160161459A1

https://www.google.com/patents/US20160161459

[/quote]

The Eco-pen appears to be very similar to the “Hmbldt” pens pictured in the bottom right corner of page 21 of the recent MYDX investor presentation slideshow:

https://seekingalpha.com/article/4054260-mydx-mydx-investor-presentation-slideshow
http://herb.co/2016/11/29/hmbldt-time-best-inventions/
https://www.cdxlife.com/ecosmartpen/

[/quote]

However, the pen is not the only new device that they will be developing. This next paragraph clearly states that there is another patent pending invention we have yet to hear about:

On February 8, 2017, MyDx, Inc. entered into an option agreement (the “Option Agreement’) with the Torque Research & Development, Inc. ("TRD"). The Option Agreement provides MyDx with the exclusive right to license two patent pending inventions (the “TRD Inventions”), and requires MyDx to make annual payments to TRD as well as royalty payments on any products that are commercialized which are based on the TRD Inventions. MyDx's rights under the Option Agreement require customary measures of performance on the part of MyDx in terms of patent cost maintenance and other payments of costs associated with the TRD Inventions. With respect to the Option Agreement, MyDx rights are broad in terms of the potential access MyDx has to use the TRD Inventions in products, and services and many of the key economic terms of a future license, should MyDx exercise it’s rights under the Option Agreement, are agreed to in the Option Agreement.

In addition to the Option Agreement with the TRD, on February 8, 2017, MyDx has entered into a research and development agreement (the “RD Agreement”) with TRD for the Project titled “Manufacturable, Medical Grade Smart Vape Devices and Related Medical Software Applications for Prescribers, Administrators and Patient Applications.” The RD Agreement allows MyDx to fund research based on the TRD Inventions with a three year budget of $280,371 and a deferred payment of $75,000 within ninety days of the Effective Date. The RD Agreement provides MyDx with an exclusive right to license all technology that is discovered from the monies funded to TRD through the RD Agreement (the “Derivative IP”). To the extent that MyDx exercises it’s rights under the RD Agreement, MyDx will be required to make customary annual payments to TRD, who shall be the owners of any Derivative IP, as well as royalty payments as any commercialization of such Derivative IP occurs. TRD may elect to accept payment in whole or in part in cash or the company’s restricted common stock priced at the Effective Date.

https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12014826

[/quote]

Trademarks, Software, and Data have been acquired from Budgenius.com:

On February 10, 2017, the Company entered into a binding term sheet to acquire certain trademarks, software, data and customer lists from Bud Genius, Inc. in exchange for 100,000,000 restricted MyDx common stock. In good faith, the parties agreed to complete all due diligence and execute transaction documents within 45 days of the date hereof. The 45 days have expired and the parties continue to negotiate in good faith to consummate the transaction.

[/quote]

There is some connection between Budtrader.com and MYDX. For starters, there are plenty of mutual links that come up in a simple google search of MYDX and Budtrader.com:

http://oregon.budtrader.com/ads/mydx-analyzer-cannadx-sensor-kit/
http://nevada.budtrader.com/ads/mydx-analyzer-cannadx-sensor-kit/
http://michigan.budtrader.com/ads/mydx-analyzer-cannadx-sensor-kit/
http://newyork.budtrader.com/ads/mydx-analyzer-cannadx-sensor-kit/
http://california.budtrader.com/ads/mydx-analyzer-cannadx-sensor-kit/

...and more but you get the point.

[/quote]

The connection between Budtrader.com and MYDX seems more likely after a look at www.MMJBuy.com (Possible Joint Venture?). You can see MYDX has their own dedicated products section on the site tabs and scroll down to bottom of the site where you can see it says:

"A place for you to buy high quality CBD, CDXlife,"
Enter Health Products

http://mmjbuy.com/

[/quote]

Here is the "whois" info and where it gets more interesting:

https://www.whois.com/whois/mmjbuy.com

The registrant of www.MMJbuy.com is [e-mail]
"Scott" is the CTO of Budtrader.com:

https://www.linkedin.com/in/scott-edge-153369128

[/quote]

Budtrader HQ is only 22min from MYDX HQ:

https://www.google.com/maps/dir/6335+Ferris+Square+b,+San+Diego,+CA+92121/533+2nd+St+%23216,+Encinitas,+CA+92024/@32.9596232,-117.30737,12z/data=!3m1!4b1!4m13!4m12!1m5!1m1!1s0x80dc075a47f7974b:0x4939d45b35515a4a!2m2!1d-117.1808914!2d32.8895429!1m5!1m1!1s0x80dc0c43ae82a1ef:0x98887024e67c7478!2m2!1d-117.2944486!2d33.0454752

[/quote]

Here is Budtrader's recent "Budtrader Ball":

BudTrader.com CEO Brad McLaughlin Invites Governor Jerry Brown to Annual 420 Ball
https://finance.yahoo.com/news/budtrader-com-ceo-brad-mclaughlin-111700227.html

[/quote]

Budtrader.com has a press release section on NASDAQ but they are a private company:

http://www.nasdaq.com/symbol/budtrader.com/news-headlines


Budtrader.com just opened up a "Google Style Campus" in San Diego:

Published on Mar 23, 2017
Budtrader, the largest medical marijuana and cannabis website in the world opened a start of the art 'Google Style' campus in San Diego California just a quarter mile from the beach. BudTrader has been featured as one of the fastest growing mmj/420 businesses in the world.
https://www.youtube.com/watch?v=1q0fTJC86sY

[/quote]

There was recently a settlement agreement with the CEO for past salary, bonus, as well as money he loaned the company. There is a warrant in effect that allows the CEO to purchase up to 15% of the common stock (over 200million more shares):

Section 1. Settlement. In exchange for Yazbeck’s settlement and release of the Settled Claims, the Company shall issue to Yazbeck or his affiliate, YCIG, Inc., common stock of the Company and warrants to purchase same (the “Settlement Amount”) and where Section 1(b)(c)(d) are further defined in the Securities Purchase Agreement (the “SPA”) attached hereto as Exhibit A, as follows:

(a)Fifty-One (51) shares of the Company’s Series A Voting Preferred Stock, $0.001 par value per share (the “Series A Preferred”);
(b)Three Hundred Thousand (300,000) at $1.00 per shares of the Company’s Series B Preferred Stock, $0.001 par value per share (the “Series B Preferred”);
(c)Warrant for fifteen percent (15%) of the common shares of the Company issued and outstanding as of January 3, 2017, at an exercise price of $0.01 per share (the “Warrant”), in form attached hereto as Exhibit B; and
(d)Thirty Million (30,000,000) shares of the Company’s Restricted Common Stock, $0.001 par value per share (the “Common Stock”).

https://www.sec.gov/Archives/edgar/data/1582341/000121390017000256/f8k121616ex10v_mydxinc.htm

MYDX has been very stable at recent prices. The warrant may minimize the risk for the common stock by providing solid support while also making sure MYDX maintains QB status going forward as well.

[/quote]

Here is an interesting mystery, possibly a coincidence. It's not only the NDT patents for the digital sensors and digital analyzer that connect MYDX to Caltech, NASA, and Dr. Nathan Lewis...it's also surprisingly the ANP Technologies deal for the single use sensors that goes back to Dr. Lewis.

The single-use MYDX sensors from ANP Technologies (Ace-III NIDS) have previously been connected to a distributor called Smith's Detection:

http://www.anptinc.com/foodpesticidetest-aceiii-c
https://www.smithsdetection.com/

Smith’s Detection To Distribute Nids® Bio-Threat System Globally:

http://www.jems.com/articles/2011/11/smiths-detection-distribute-nids-bio-thr.html

It has also been previously mentioned that there used to be an early stage E-nose company called Cyrano. Cyrano was the original E-nose company, spun out of Caltech/NASA and founded by Dr. Nathan Lewis himself in 1997:

https://spinoff.nasa.gov/spinoff2001/ps4.html

“Cyrano Sciences was founded by Nathan S. Lewis, Robert H. Grubbs, and Rodney M Goodman, all engineering professors at the California Institute of Technology.”
https://www.bioprocessonline.com/doc/hewlett-packard-cyrano-sciences-sign-electron-0001


Cyrano was ultimately acquired by Smiths Group plc (LSE: SMIN) and was promptly renamed as their new subsidiary, Smith’s Detection:

https://www.crunchbase.com/acquisition/637089d766f50e6aedb77297059b6ac9

https://en.wikipedia.org/wiki/Smiths_Group

So,
1.) Not only is Dr. Nathan Lewis the inventor on almost every patent that MYDX has exclusively licensed from NDT (Dr. Lewis’s company) for the digital sensors and digital analyzer.
But,
2.) Dr. Lewis also founded Cyrano, which later became Smith’s Detection, which happens to be the only distributor ever licensed to distribute the ANP Technologies single-use enzyme based sensors until the recent licensing to MYDX.

The MYDX e-nose technology and the MYDX single use sensors are completely different technologies and products. Why is it that Dr. Lewis is the inventor of one of them and the founder of what became the main distribution company of the other?

[/quote]

Here's some info on the supplier of the MyDx single use sensors, ANP Technologies:

"ANP Technologies®, Inc., originally spun out from the U.S. Army Research Laboratory in 2002, is an innovation-driven company which has successfully developed multiple product platforms based on proprietary/patented nanobiomaterials and the nanoscale manipulation of their spatial orientation."

http://www.anptinc.com/about-us

Here is the President of ANP, Dr. Ray Yin, with quite an impressive resume:
http://www.delawarebio.org/assets/files/Other/Ray-Yin-Bio.pdf

Recent Press Releases:
http://www.anptinc.com/press-releases

[/quote]

Last but not least, the most recent addition to the MYDX product lines is MyDx 360. MyDx 360 is a Software As A Service (SAAS)-based community engagement platform designed to help entrepreneurs develop, launch and track the effects of new products on consumers to help penetrate their target markets more effectively.

As part of the service, companies will choose from among MyDx’s many chemical formulations that best align with the ailments its target demographic is seeking to alleviate. From there, MyDx will outsource the delivery of those formulations through licensed concentrate manufacturing facilities and provide customer-engagement support via its SAAS platform to acquire and analyze user feedback. Collectively, this suite of services will be called MyDx360.

The purpose of MyDx360 is three-fold:
1.) Bridge the relationship gap between customers and companies
2.) Facilitate real-time feedback to help companies respond to changing market trends
3.) Provide soup to nuts coverage of formulated-concentrates

https://www.cdxlife.com/mydx360/
https://www.cdxlife.com/wp-content/uploads/MyDx360-Brand-SAAS-Platform.pdf

[/quote]

Budtrader Campus in San Diego
https://www.youtube.com/watch?v=1q0fTJC86sY

[/quote]
v/r
Sterling